MoneyWorks4Me

Hester Biosciences informs about teleconference call

15 May 2023 Evaluate

Hester Biosciences has informed that, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the Company has scheduled investor interaction through a teleconference call on Wednesday, 17 May 2023 at 2:00 pm (IST), post the announcement of unaudited financial results for the quarter and year ended 31 March 2023. Details for joining the call are attached.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1748.90
Dr. Reddys Labs. 1214.10
Cipla 1312.85
Lupin 1954.80
Zydus Lifesciences 1124.00
View more..